Bart Thomas Gatewood, - Pharmacist in Hobbs, NM

Bart Thomas Gatewood, is a Pharmacist based in Hobbs, New Mexico. Bart Thomas Gatewood is licensed to practice in New Mexico (license number RPH00007323) and his current practice location is 2420 N Fowler St, Hobbs, New Mexico. He can be reached at his office (for appointments etc.) via phone at (575) 392-6516.

NPI number for Bart Thomas Gatewood is 1255561585 and his current mailing address is 2420 N Fowler St, Hobbs, New Mexico. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1255561585.

Contact Information

Bart Thomas Gatewood,
2420 N Fowler St,
Hobbs, NM 88240-2347
(575) 392-6516
(575) 392-8236

Healthcare Provider's Profile

Full NameBart Thomas Gatewood
GenderMale
SpecialityPharmacist
Location2420 N Fowler St, Hobbs, New Mexico
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1255561585
  • Provider Enumeration Date: 07/21/2009
  • Last Update Date: 07/21/2009

Medical Identifiers

Medical identifiers for Bart Thomas Gatewood such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1255561585NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist RPH00007323 (New Mexico)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bart Thomas Gatewood is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Bart Thomas Gatewood,
2420 N Fowler St,
Hobbs, NM 88240-2347

Ph: (575) 392-6516
Bart Thomas Gatewood,
2420 N Fowler St,
Hobbs, NM 88240-2347

Ph: (575) 392-6516

News Archive

Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

Actavis plc today announced positive top-line results for study DUR001-303, a phase 3 study comparing a single 1500 mg dose of DALVANCE with the same total dose given as two-doses one week apart, for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including methicillin resistant Staphylococcus aureus (MRSA).

Man-made waterways contribute to malaria breeding grounds, study suggests

A recent study, conducted by Elizabeth Whitcombe, visiting senior research scholar at the earth system science interdisciplinary center at the University of Maryland, and published in the May 13 issue of Philosophical Transactions of the Royal Society, "mapped meteorological, irrigation and medical reports during British rule in India" and concluded modern-day India should learn lessons from the past to improve engineering plans and epidemiological "modeling of environmental factors controlling vector borne disease," especially malaria, SciDev.Net reports.

Large-scale screening programme of tonsil tissue is the only way of identifying the true incidence of vCJD infection

A study in this week's issue of THE LANCET describes how two different types of analysis used in conjunction on samples of tonsil tissue is the ‘gold standard' method for confirming clinical variant CJD

More investment in family planning and pregnancy-related care will reduce maternal and newborn deaths

Maternal deaths in developing countries could be slashed by 70% and newborn deaths cut nearly in half if the world doubled investment in family planning and pregnancy-related care, shows a new report by the Guttmacher Institute and UNFPA, the United Nations Population Fund. Currently, more than half a million maternal deaths and 3.5 million newborn deaths, many of them easily preventable, occur each year in developing countries.

Read more News

› Verified 3 days ago


Pharmacist in Hobbs, NM

Clarisse Baba,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 801 W Joe Harvey Blvd, Hobbs, NM 88240
Phone: 575-392-0053    
Dr. Kimberly Madrid, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 5419 N Lovington Hwy, Hobbs, NM 88240
Phone: 575-492-5174    
Caleb Uebelein, PHARM.D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 3800 N Lovington Hwy, Hobbs, NM 88240
Phone: 575-492-0310    
Saquib Mohammed, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 3800 N Lovington Hwy, Hobbs, NM 88240
Phone: 575-492-0120    
Dr. Keith Holguin, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1401 N Turner St, Hobbs, NM 88240
Phone: 575-393-2767    
Chelsea Lynn Griebel, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 801 W Joe Harvey Blvd, Hobbs, NM 88240
Phone: 575-392-0053    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.